InvestorsHub Logo
Followers 20
Posts 2687
Boards Moderated 1
Alias Born 12/03/2020

Re: misiu143 post# 228660

Friday, 01/05/2024 9:01:21 AM

Friday, January 05, 2024 9:01:21 AM

Post# of 233146

But not our Leronlimab , as a great immune- mmodulator it is normalizing both situation !!!
If our immune system is hyper or it is hypo !!!
And our phase 2 study for LC showed that very accurately ..


Another LIE, it certainly DID NOT show "very accurately", nor even "showed". For Misiu's followers, I am a statistician by academic training and profession, here is why I state this:
the numbers in the study were not statistically significant, AND the statistical significance tests were NOT adjusted for data dredging. Said more simply, we are interpreting noise, random luck, chance, however this may be called, COUPLED with the hand picking by the study authors of whatever statistic suited their story amongst dozen statistics which were NOT published and conveniently kept hidden (because these didn't demonstrate the desired effect).

I did not invent this, one just needs to read the very first paragraph of the "Results" section of the study itself:
The mean symptom score changes from baseline to the latest available time point from day 30–56 for leronlimab vs placebo were –16.0 and –12.0, respectively; adjusting for prespecified covariates, the adjusted mean difference was –1.0 (not statistically significant; Supplementary Table 2). For several symptoms, there was a numerically higher percentage of participants with reduced raw symptom scores for leronlimab compared with placebo treatment (Supplementary Figure 2), reaching borderline statistical significance without correction for multiple comparisons due to the exploratory nature of this pilot study.

The study itself doesn't say "show" or use any word like "very accurate", but only "suggests". Classical Misiu exageration...no wonder the stock lost -96% while each and every of her predictions failed to realize...

PS: another red flag is that a study co-author is Nader Pourhassan, a twice felon currently investigated by the SEC and under a lawsuit, that has lost all the past Cytodyn lawsuits while at its helm. The guy is a walking fraud, caracterized by a judge as having demonstrated "unmitigated greed". The only poster that supports him is Misiu, as if by chance... Anything coming from these 2 liers is tainted and should be treated with extreme care, sources should be independantly verified, documents shall be read entirely and from an official source, etc...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News